X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (33054) 33054
Newspaper Article (166) 166
Newsletter (107) 107
Book Chapter (91) 91
Magazine Article (85) 85
Book / eBook (50) 50
Dissertation (4) 4
Book Review (3) 3
Conference Proceeding (2) 2
Government Document (2) 2
Reference (2) 2
Streaming Video (2) 2
Web Resource (2) 2
Report (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29040) 29040
female (16853) 16853
male (15020) 15020
middle aged (12195) 12195
skin neoplasms - pathology (12108) 12108
aged (10300) 10300
adult (8918) 8918
oncology (8171) 8171
dermatology (7902) 7902
cancer (6949) 6949
melanoma (6799) 6799
skin (5736) 5736
melanoma - secondary (5078) 5078
metastasis (4906) 4906
surgery (4576) 4576
aged, 80 and over (4471) 4471
animals (4442) 4442
tumors (4321) 4321
skin cancer (4255) 4255
skin neoplasms - secondary (4118) 4118
melanoma - pathology (3954) 3954
prognosis (3356) 3356
skin and connective tissue diseases (3262) 3262
skin neoplasms - surgery (3196) 3196
care and treatment (3139) 3139
treatment outcome (3095) 3095
immunohistochemistry (2962) 2962
breast cancer (2959) 2959
pathology (2920) 2920
mice (2916) 2916
skin neoplasms - diagnosis (2905) 2905
skin neoplasms - drug therapy (2891) 2891
research (2873) 2873
expression (2666) 2666
retrospective studies (2634) 2634
lymphatic metastasis (2493) 2493
cell line, tumor (2488) 2488
diagnosis (2471) 2471
analysis (2433) 2433
diagnosis, differential (2360) 2360
risk factors (2321) 2321
skin neoplasms - metabolism (2248) 2248
biopsy (2204) 2204
adolescent (2192) 2192
chemotherapy (2136) 2136
health aspects (2094) 2094
neoplasm staging (2085) 2085
breast neoplasms - pathology (2054) 2054
skin neoplasms - therapy (2030) 2030
skin neoplasms - genetics (2029) 2029
malignant-melanoma (1980) 1980
follow-up studies (1965) 1965
medicine (1956) 1956
research article (1948) 1948
cell biology (1885) 1885
apoptosis (1836) 1836
patients (1797) 1797
medicine & public health (1787) 1787
survival (1741) 1741
carcinoma (1726) 1726
melanoma - drug therapy (1726) 1726
proteins (1683) 1683
skin - pathology (1650) 1650
metastases (1618) 1618
mutation (1612) 1612
gene expression (1600) 1600
young adult (1594) 1594
melanoma - surgery (1579) 1579
therapy (1544) 1544
neoplasms (1531) 1531
lung neoplasms - secondary (1471) 1471
cancer therapies (1448) 1448
antineoplastic agents - therapeutic use (1447) 1447
squamous cell carcinoma (1445) 1445
development and progression (1406) 1406
genetic aspects (1389) 1389
child (1369) 1369
skin neoplasms - mortality (1359) 1359
multidisciplinary sciences (1347) 1347
melanoma - diagnosis (1342) 1342
carcinoma, squamous cell - pathology (1307) 1307
neoplasm metastasis (1275) 1275
time factors (1247) 1247
melanoma - genetics (1234) 1234
fatal outcome (1212) 1212
radiotherapy (1179) 1179
survival rate (1176) 1176
melanoma - mortality (1150) 1150
studies (1150) 1150
immunotherapy (1147) 1147
kinases (1142) 1142
melanoma - metabolism (1140) 1140
science (1139) 1139
melanoma - therapy (1129) 1129
disease progression (1125) 1125
gene expression regulation, neoplastic (1121) 1121
cell proliferation (1115) 1115
medical research (1113) 1113
neoplasm invasiveness (1101) 1101
medicine, research & experimental (1096) 1096
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (31877) 31877
French (491) 491
German (425) 425
Spanish (276) 276
Japanese (200) 200
Italian (95) 95
Russian (91) 91
Polish (73) 73
Chinese (38) 38
Hungarian (31) 31
Czech (28) 28
Portuguese (25) 25
Dutch (22) 22
Danish (21) 21
Korean (12) 12
Turkish (11) 11
Hebrew (10) 10
Romanian (8) 8
Serbian (8) 8
Croatian (7) 7
Norwegian (6) 6
Slovak (6) 6
Bulgarian (4) 4
Arabic (3) 3
Finnish (3) 3
Swedish (3) 3
Greek (2) 2
Icelandic (1) 1
Manx (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2008, Volume 60, Issue 3, pp. 379 - 387
Background Previous reports regarding the rates at which various internal tumors metastasize to the skin have been limited and have only included the Caucasian... 
Dermatology | LUNG-CANCER | PROGNOSTIC-FACTORS | ASIAN ETHNICITY | BREAST-CANCER METASTASIS | SKIN-ASSOCIATED CHEMOKINE | BASAL-CELL CARCINOMA | WHITE WOMEN | DRINKING-WATER | AFRICAN-AMERICAN | CHINESE WOMEN | DERMATOLOGY | Immunohistochemistry | Lung Neoplasms - ethnology | Academic Medical Centers - statistics & numerical data | Carcinoma, Squamous Cell - metabolism | Humans | Lung Neoplasms - metabolism | Carcinoma, Transitional Cell - secondary | Lung Neoplasms - pathology | Mouth Neoplasms - metabolism | Carcinoma, Hepatocellular - secondary | Carcinoma, Transitional Cell - ethnology | Breast Neoplasms - metabolism | Carcinoma, Squamous Cell - ethnology | Gastrointestinal Neoplasms - pathology | Mouth Neoplasms - ethnology | Adenocarcinoma - metabolism | Urinary Bladder Neoplasms - pathology | Liver Neoplasms - pathology | Retrospective Studies | Adenocarcinoma - ethnology | Breast Neoplasms - ethnology | Urinary Bladder Neoplasms - metabolism | Carcinoma, Hepatocellular - ethnology | Gastrointestinal Neoplasms - metabolism | Receptors, CCR10 - metabolism | Skin Neoplasms - ethnology | Carcinoma, Transitional Cell - metabolism | Adenocarcinoma - secondary | Receptors, CXCR4 - metabolism | Skin Neoplasms - metabolism | Liver Neoplasms - ethnology | Breast Neoplasms - pathology | Taiwan - epidemiology | Liver Neoplasms - metabolism | Skin Neoplasms - secondary | Mouth Neoplasms - pathology | Carcinoma, Squamous Cell - secondary | Gastrointestinal Neoplasms - ethnology | Asian Continental Ancestry Group - statistics & numerical data | Carcinoma, Hepatocellular - metabolism | Urinary Bladder Neoplasms - ethnology | Medical colleges | Hospitals | Metastasis | Medical centers | Cancer
Journal Article
American Journal of Pathology, ISSN 0002-9440, 2010, Volume 177, Issue 4, pp. 1647 - 1656
Phosphatase and tensin homolog (PTEN) is a key modulator of trastuzumab sensitivity in HER2-overexpressing breast cancer. Because PTEN opposes the downstream... 
ADJUVANT CHEMOTHERAPY | INHIBITION | THERAPY | PROTEIN | HUMAN-BREAST-CANCER | PATHWAY | MUTATIONS | PATHOLOGY | RECEPTORS | TRASTUZUMAB RESISTANCE | EXPRESSION | Lung Neoplasms - drug therapy | Receptors, Estrogen - metabolism | Receptor, ErbB-2 - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Immunoenzyme Techniques | Receptors, Progesterone - metabolism | Young Adult | Carcinoma, Ductal, Breast - drug therapy | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Proto-Oncogene Proteins c-akt - metabolism | Carcinoma, Ductal, Breast - metabolism | PTEN Phosphohydrolase - genetics | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | Survival Rate | Lymphatic Metastasis | Brain Neoplasms - drug therapy | Mutation - genetics | Breast Neoplasms - drug therapy | Class I Phosphatidylinositol 3-Kinases | Carcinoma, Lobular - metabolism | Trastuzumab | Bone Neoplasms - mortality | Phosphorylation | Prognosis | Receptor, ErbB-2 - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Liver Neoplasms - mortality | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Brain Neoplasms - secondary | In Situ Hybridization | Lung Neoplasms - secondary | Adult | Female | Bone Neoplasms - drug therapy | Neoplasm Invasiveness | Liver Neoplasms - drug therapy | PTEN Phosphohydrolase - metabolism | Phosphatidylinositol 3-Kinases - genetics | Breast Neoplasms - mortality | Aged | Carcinoma, Lobular - drug therapy | Regular
Journal Article
Oral Oncology, ISSN 1368-8375, 2013, Volume 49, Issue 1, pp. 79 - 85
Summary Objectives To describe the natural course of distant metastases (DMs) following radiotherapy (RT) or chemoradiotherapy (CRT) in HPV(+) oropharyngeal... 
Otolaryngology | Hematology, Oncology and Palliative Medicine | Distant metastasis | Human papillomavirus | Oropharyngeal carcinoma | Radiotherapy | Chemoradiotherapy | SURVIVAL | HEAD | HUMAN-PAPILLOMAVIRUS | P16(INK4A) | SUBSET | PHASE-III TRIAL | NASOPHARYNGEAL CARCINOMA | ONCOLOGY | DENTISTRY, ORAL SURGERY & MEDICINE | SQUAMOUS-CELL CARCINOMA | EPSTEIN-BARR-VIRUS | NECK-CARCINOMA | Oropharyngeal Neoplasms - therapy | Papillomavirus Infections - radiotherapy | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Carcinoma - virology | Salvage Therapy | Male | Papillomavirus Infections - therapy | Neoplasm Recurrence, Local - pathology | Lung Neoplasms - secondary | Tongue Neoplasms - virology | Aged, 80 and over | Adult | Female | Retrospective Studies | Tonsillar Neoplasms - therapy | Liver Neoplasms - secondary | Carcinoma - secondary | Tongue Neoplasms - radiotherapy | Liver Neoplasms - virology | Radiotherapy Dosage | Tongue Neoplasms - therapy | Alphapapillomavirus - classification | Oropharyngeal Neoplasms - radiotherapy | Survival Rate | Oropharyngeal Neoplasms - virology | Carcinoma - radiotherapy | Lung Neoplasms - virology | Tonsillar Neoplasms - radiotherapy | Tonsillar Neoplasms - virology | Skin Neoplasms - virology | Skin Neoplasms - secondary | Carcinoma - therapy | Aged | Neoplasm Staging | Cohort Studies | Care and treatment | Metastasis | Nuclear radiation | Papillomavirus infections | Cancer
Journal Article
BMC cancer, ISSN 1471-2407, 2006, Volume 6, Issue 1, pp. 225 - 225
Background: HER2/neu overexpression is linked to promotion of angiogenesis in breast cancer. We therefore tested the activity of the combination of Trastuzumab... 
PROTEIN | ANGIOGENESIS | ONCOLOGY | NEU ONCOGENE | EPIDERMAL-GROWTH-FACTOR | IN-VIVO | PHASE-II | MONOCLONAL-ANTIBODY | ANTITUMOR-ACTIVITY | FACTOR RECEPTOR | PLUS | Lung Neoplasms - drug therapy | Cyclophosphamide - administration & dosage | Humans | Middle Aged | Neoplasm Proteins - immunology | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Neoplasm Proteins - antagonists & inhibitors | Cyclophosphamide - adverse effects | Bone Neoplasms - blood supply | Leukopenia - chemically induced | Receptor, ErbB-2 - antagonists & inhibitors | Receptor, ErbB-2 - immunology | Liver Neoplasms - secondary | Combined Modality Therapy | Lung Neoplasms - therapy | Lymphatic Metastasis | Breast Neoplasms - blood supply | Brain Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Remission Induction | Methotrexate - adverse effects | Breast Neoplasms - genetics | Brain Neoplasms - therapy | Immunization, Passive | Methotrexate - administration & dosage | Trastuzumab | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Bone Neoplasms - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Brain Neoplasms - blood supply | Liver Neoplasms - therapy | Ventricular Dysfunction, Left - chemically induced | Breast Neoplasms - therapy | Antibodies, Monoclonal, Humanized | Brain Neoplasms - secondary | Lung Neoplasms - secondary | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Bone Neoplasms - drug therapy | Neutropenia - chemically induced | Lung Neoplasms - blood supply | Drug Administration Schedule | Liver Neoplasms - drug therapy | Treatment Outcome | Gene Amplification | Liver Neoplasms - blood supply | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Genes, erbB-2 | Aged
Journal Article
Surgery today (Tokyo, Japan), ISSN 1436-2813, 2012, Volume 42, Issue 8, pp. 752 - 758
The results and outcomes of surgical resection for esophageal carcinoma have improved remarkably in recent years; however, recurrence still frequently... 
Recurrence | Medicine & Public Health | Cardiac Surgery | Surgery | Abdominal Surgery | Vascular Surgery | Thoracic Surgery | Surgical Oncology | Esophageal cancer | LYMPH-NODE DISSECTION | 2-FIELD | POSITRON-EMISSION-TOMOGRAPHY | EXTENDED RADICAL ESOPHAGECTOMY | THORACIC ESOPHAGUS | DISEASE | SQUAMOUS-CELL CARCINOMA | CURATIVE RESECTION | 3-FIELD LYMPHADENECTOMY | Bone Neoplasms - mortality | Bone Neoplasms - therapy | Follow-Up Studies | Lung Neoplasms - mortality | Carcinoma, Squamous Cell - pathology | Humans | Bone Neoplasms - secondary | Carcinoma, Squamous Cell - surgery | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Esophageal Neoplasms - pathology | Carcinoma, Squamous Cell - mortality | Lung Neoplasms - secondary | Time Factors | Esophageal Neoplasms - surgery | Skin Neoplasms - mortality | Skin Neoplasms - diagnosis | Esophageal Neoplasms - mortality | Retrospective Studies | Liver Neoplasms - secondary | Bone Neoplasms - diagnosis | Skin Neoplasms - therapy | Neoplasm Recurrence, Local - therapy | Kaplan-Meier Estimate | Esophagectomy | Survival Rate | Treatment Outcome | Combined Modality Therapy | Lung Neoplasms - therapy | Lymphatic Metastasis | Neoplasm Recurrence, Local - diagnosis | Liver Neoplasms - diagnosis | Skin Neoplasms - secondary | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - diagnosis | Neoplasm Staging | Neck Dissection
Journal Article
Breast cancer research : BCR, ISSN 1465-542X, 2010, Volume 12, Issue 5, pp. R75 - R75
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2018, Volume 155, Issue 1, pp. 33 - 37.e6
We studied the effects of gut microbiome depletion by oral antibiotics on tumor growth in subcutaneous and liver metastases models of pancreatic cancer, colon... 
Immune Regulation | Tumor Promotion | Gut Bacteria | Metastases | GASTROENTEROLOGY & HEPATOLOGY | IL-17 | T-Lymphocyte Subsets - immunology | Neoplasm Transplantation | Interleukin-17 - immunology | Soft Tissue Neoplasms - immunology | Dysbiosis - immunology | Melanoma, Experimental - immunology | Neoplasm Metastasis - immunology | Melanoma, Experimental - secondary | Liver Neoplasms - secondary | Carcinoma - secondary | Disease Models, Animal | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Soft Tissue Neoplasms - secondary | Pancreatic Neoplasms - pathology | Liver Neoplasms - immunology | Melanoma - secondary | Mice, Knockout | Tumor Microenvironment - immunology | Animals | Gastrointestinal Microbiome - drug effects | Melanoma - immunology | Neoplasms - immunology | Colonic Neoplasms - pathology | Interferon-gamma - immunology | Pancreatic Neoplasms - immunology | Cell Line, Tumor | T-Lymphocytes - immunology | Anti-Bacterial Agents - pharmacology | Mice | Gastrointestinal Microbiome - immunology | Interleukin-10 - immunology | Medical colleges | Microbiota (Symbiotic organisms) | Growth | Liver | Melanoma | Metastasis | B cells | T cells | Biological response modifiers | Liver cancer | Colon cancer | Interleukins | Immunotherapy | Pancreatic cancer | Bacteria | Interferon gamma | metastases | gut bacteria | immune regulation | tumor promotion
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 2, pp. 293 - 295
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2015, Volume 33, Issue 34, pp. 4032 - 4038
Journal Article
Human Pathology, ISSN 0046-8177, 2012, Volume 43, Issue 7, pp. 1003 - 1011
Journal Article